GNRH1 and type 2 diabetes mellitus: These findings support the previous data indicating the association between GnRH and increased risk of CVD, and highlight the need to closely monitor lipid levels and to be ready to intensify lipid-lowering therapy in men with T2DM and PCa starting treatment with GnRH.